180 related articles for article (PubMed ID: 28957426)
1. Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host.
Chopra-Dewasthaly R; Spergser J; Zimmermann M; Citti C; Jechlinger W; Rosengarten R
PLoS Pathog; 2017 Sep; 13(9):e1006656. PubMed ID: 28957426
[TBL] [Abstract][Full Text] [Related]
2. Xer1-independent mechanisms of Vpma phase variation in Mycoplasma agalactiae are triggered by Vpma-specific antibodies.
Czurda S; Hegde SM; Rosengarten R; Chopra-Dewasthaly R
Int J Med Microbiol; 2017 Dec; 307(8):443-451. PubMed ID: 29122515
[TBL] [Abstract][Full Text] [Related]
3. Novel role of Vpmas as major adhesins of Mycoplasma agalactiae mediating differential cell adhesion and invasion of Vpma expression variants.
Hegde S; Zimmermann M; Rosengarten R; Chopra-Dewasthaly R
Int J Med Microbiol; 2018 Mar; 308(2):263-270. PubMed ID: 29229193
[TBL] [Abstract][Full Text] [Related]
4. Xer1-mediated site-specific DNA inversions and excisions in Mycoplasma agalactiae.
Czurda S; Jechlinger W; Rosengarten R; Chopra-Dewasthaly R
J Bacteriol; 2010 Sep; 192(17):4462-73. PubMed ID: 20562305
[TBL] [Abstract][Full Text] [Related]
5. Role of Vpma phase variation in Mycoplasma agalactiae pathogenesis.
Chopra-Dewasthaly R; Baumgartner M; Gamper E; Innerebner C; Zimmermann M; Schilcher F; Tichy A; Winter P; Jechlinger W; Rosengarten R; Spergser J
FEMS Immunol Med Microbiol; 2012 Dec; 66(3):307-22. PubMed ID: 22809092
[TBL] [Abstract][Full Text] [Related]
6. Phase-locked mutants of Mycoplasma agalactiae: defining the molecular switch of high-frequency Vpma antigenic variation.
Chopra-Dewasthaly R; Citti C; Glew MD; Zimmermann M; Rosengarten R; Jechlinger W
Mol Microbiol; 2008 Mar; 67(6):1196-210. PubMed ID: 18248580
[TBL] [Abstract][Full Text] [Related]
7. Sheep Infection Trials with 'Phase-Locked' Vpma Expression Variants of
Chopra-Dewasthaly R; Dagn A; Lohinger C; Brunthaler R; Flöck M; Kargl M; Hegde S; Spergser J; Rosengarten R
Microorganisms; 2022 Apr; 10(4):. PubMed ID: 35456865
[TBL] [Abstract][Full Text] [Related]
8. Surface diversity in Mycoplasma agalactiae is driven by site-specific DNA inversions within the vpma multigene locus.
Glew MD; Marenda M; Rosengarten R; Citti C
J Bacteriol; 2002 Nov; 184(21):5987-98. PubMed ID: 12374833
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a multigene family undergoing high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae.
Glew MD; Papazisi L; Poumarat F; Bergonier D; Rosengarten R; Citti C
Infect Immun; 2000 Aug; 68(8):4539-48. PubMed ID: 10899853
[TBL] [Abstract][Full Text] [Related]
10. Predominant Single Stable VpmaV Expression in Strain GM139 and Major Differences with
Barbosa MS; Spergser J; Marques LM; Timenetsky J; Rosengarten R; Chopra-Dewasthaly R
Animals (Basel); 2022 Jan; 12(3):. PubMed ID: 35158589
[TBL] [Abstract][Full Text] [Related]
11. Occurrence, plasticity, and evolution of the vpma gene family, a genetic system devoted to high-frequency surface variation in Mycoplasma agalactiae.
Nouvel LX; Marenda M; Sirand-Pugnet P; Sagné E; Glew M; Mangenot S; Barbe V; Barré A; Claverol S; Citti C
J Bacteriol; 2009 Jul; 191(13):4111-21. PubMed ID: 19376859
[TBL] [Abstract][Full Text] [Related]
12. Experimental infections with Mycoplasma agalactiae identify key factors involved in host-colonization.
Baranowski E; Bergonier D; Sagné E; Hygonenq MC; Ronsin P; Berthelot X; Citti C
PLoS One; 2014; 9(4):e93970. PubMed ID: 24699671
[TBL] [Abstract][Full Text] [Related]
13. Serum Resistance of
Sommer K; Kowald S; Chopra-Dewasthaly R
Pathogens; 2022 Sep; 11(9):. PubMed ID: 36145468
[TBL] [Abstract][Full Text] [Related]
14. Validation of the suppressive subtractive hybridization method in Mycoplasma agalactiae species by the comparison of a field strain with the type strain PG2.
Marenda MS; Vilei EM; Poumarat F; Frey J; Berthelot X
Vet Res; 2004; 35(2):199-212. PubMed ID: 15099496
[TBL] [Abstract][Full Text] [Related]
15. Genetic loci of Mycoplasma agalactiae involved in systemic spreading during experimental intramammary infection of sheep.
Hegde S; Zimmermann M; Flöck M; Brunthaler R; Spergser J; Rosengarten R; Chopra-Dewasthaly R
Vet Res; 2016 Oct; 47(1):106. PubMed ID: 27765069
[TBL] [Abstract][Full Text] [Related]
16. [Molecular basis of Mycoplasma agalactiae pathogenicity].
Jechlinger W; Chopra-Dewasthaly R; Glew M; Citti C; Rosengarten R
Berl Munch Tierarztl Wochenschr; 2004; 117(11-12):472-9. PubMed ID: 15584429
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive RNA-Seq Profiling to Evaluate the Sheep Mammary Gland Transcriptome in Response to Experimental Mycoplasma agalactiae Infection.
Chopra-Dewasthaly R; Korb M; Brunthaler R; Ertl R
PLoS One; 2017; 12(1):e0170015. PubMed ID: 28081235
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo cell invasion and systemic spreading of Mycoplasma agalactiae in the sheep infection model.
Hegde S; Hegde S; Spergser J; Brunthaler R; Rosengarten R; Chopra-Dewasthaly R
Int J Med Microbiol; 2014 Nov; 304(8):1024-31. PubMed ID: 25129554
[TBL] [Abstract][Full Text] [Related]
19. Identification of conserved Mycoplasma agalactiae surface antigens by immunoproteomics.
Cacciotto C; Addis MF; Pagnozzi D; Coradduzza E; Pittau M; Alberti A
Vet Immunol Immunopathol; 2021 Jun; 236():110239. PubMed ID: 33845295
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Recombinant P48 of Mycoplasma agalactiae by Site Directed Mutagenesis and its Immunological Characterization.
Cheema PS; Singh S; Kathiresan S; Kumar R; Bhanot V; Singh VP
Anim Biotechnol; 2017 Jan; 28(1):11-17. PubMed ID: 27385225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
